Med-tech insiders: ACA is a hidden opportunity
The Affordable Care Act and its 2.3% medical device tax represent a hidden opportunity, according to panelists at a Healthcare Businesswomen's Assn.event last night in Boston.
The women of Boston's Healthcare Businesswomen's Assn. are acutely aware of the hurdles in healthcare reform, and they're not going to take them sitting down. Participants critically evaluated the implications of the Affordable Care Act during a 2-hour panel discussion yesterday.
Despite the 2.3% medical device tax facing the med-tech industry and the uncertainty caused by the ACA reforms, the panelists spoke confidently about each challenge as an opportunity in hiding.
"I have been in this industry for 20 years, and I learned in my first year that you really have to take action to influence reform – you can't just be a recipient," said Tamima Itani, vice president of global affairs at Boston Scientific (NYSE:BSX). "I don't believe in us being victims. I believe we can shake up the industry."